MLE-4901

CAS No. 941690-55-7

MLE-4901 ( MLE4901;AZD-2624;AZD2624;Pavinetant )

Catalog No. M16736 CAS No. 941690-55-7

A potent, selective, orally active neurokinin 3 (NK3R) antagonist for the treatment of schizophrenia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MLE-4901
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective, orally active neurokinin 3 (NK3R) antagonist for the treatment of schizophrenia.
  • Description
    A potent, selective, orally active neurokinin 3 (NK3R) antagonist for the treatment of schizophrenia; demonstrates drug-like properties with low metabolic turnover rate in vitro and moderate human plasma protein binding.Schizophrenia Phase 2 Discontinued
  • Synonyms
    MLE4901;AZD-2624;AZD2624;Pavinetant
  • Pathway
    GPCR/G Protein
  • Target
    Neurokinin Receptor
  • Recptor
    Neurokinin Receptor
  • Research Area
    Neurological Disease
  • Indication
    Schizophrenia

Chemical Information

  • CAS Number
    941690-55-7
  • Formula Weight
    459.56
  • Molecular Formula
    C26H25N3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 50 mg/mL 108.80 mM; H2O : < 0.1 mg/mL
  • SMILES
    O=C(C1=C(NS(=O)(C)=O)C(C2=CC=CC=C2)=NC3=CC=CC=C13)N[C@H](C4=CC=CC=C4)CC
  • Chemical Name
    (S)-3-(methylsulfonamido)-2-phenyl-N-(1-phenylpropyl)quinoline-4-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Li Y, et al. Xenobiotica. 2010 Nov;40(11):721-9.
2. Skorupskaite K, et al. Neuroendocrinology. 2017 Apr 5. doi: 10.1159/000473893.
3. Prague JK, et al. Lancet. 2017 May 6;389(10081):1809-1820.
molnova catalog
related products
  • Fezolinetant

    A potent, selective, orally active neurokinin-3 receptor (NK3R) antagonist with pIC50/pKi of 7.7/7.6.

  • Ibodutant

    A potent and selective linear tachykinin NK2 receptor antagonist with pKb of 9.3; displays >1,000-fold selectivity over NK1 and NK3 (pKb<6).

  • 4-Oxoisotretinoin

    4-oxo-isotretinoin is the major blood metabolite.